Natco

Premium

J&J, Momenta Pharma file patent infringement lawsuit against Natco, Mylan

Johnson & Johnson and Momenta Pharmaceuticals lawsuit alleges infringement of two old patents associated with 20mg/ml and 40mg/ml Glatiramer Acetate injection, Natco said in a regulatory filing.

Updated On: 02 Aug 2023 | 10:18 AM IST

Natco starts phase-3 trials of Molnupiravir capsules for Covid-19 treatment

Natco Pharma on Friday said it has initiated phase-III clinical trials of Molnupiravir capsules to evaluate its efficacy in treating patients with mild COVID-19.

Updated On: 21 May 2021 | 7:43 PM IST

Taiho Pharma moves US court against Natco for patent infringement

Taiho alleged that the Indian drug maker's proposed generic Lonsurf (trifluridine and tipiracil) will infringe the patent

Updated On: 02 Jan 2020 | 10:28 PM IST

Premium

Delhi HC rules in favour of Indian pharma manufacturers Natco and Alembic

Allows companies to export cancer and blood thinning drugs for experimental purposes

Updated On: 09 Mar 2017 | 12:07 AM IST